When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Tocilizumab - Wikipedia

   en.wikipedia.org/wiki/Tocilizumab

   Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).

3. Here’s how to pay the lowest prices for your prescription ...

   www.aol.com/finance/pay-lowest-prices...

   See if its manufacturer offers a Patient Assistance Program (PAP) that could provide the medication for free, or at a dramatically reduced price, for a period of time. These pharmaceutical ...

4. PAN Foundation - Wikipedia

   en.wikipedia.org/wiki/PAN_Foundation

   Through its more than 80 disease-specific financial assistance programs, PAN serves well over 100,000 patients each year from every US state and territory. [4] Without the PAN Foundation’s support, these patients would have faced impossible choices—with many simply going without their life-saving treatment.

5. FDA Approves ACTEMRA® for Children Living with a Rare ... - AOL

   www.aol.com/2013/04/30/fda-approves-actemra-for...

   FDA Approves ACTEMRA ® for Children Living with a Rare Form of Arthritis Medicine Offers a New Option for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (PJIA) SOUTH SAN FRANCISCO ...

6. FDA Approves Expanded Indication for ACTEMRA® in ... - AOL

   www.aol.com/news/2012-10-12-fda-approves...

   FDA Approves Expanded Indication for ACTEMRA ® in Rheumatoid Arthritis SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY ...

7. Genentech - Wikipedia

   en.wikipedia.org/wiki/Genentech

   Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [6]